• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

包涵体肌炎的长期肌力和功能状态以及轨迹亚组的鉴定。

Long-term strength and functional status in inclusion body myositis and identification of trajectory subgroups.

机构信息

NIHR Manchester Biomedical Research Centre, Manchester University NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, United Kingdom.

Centre for Musculoskeletal Research, University of Manchester, Manchester Academic Health Science Centre, Manchester, United Kingdom.

出版信息

Muscle Nerve. 2020 Jul;62(1):76-82. doi: 10.1002/mus.26859. Epub 2020 Mar 13.

DOI:10.1002/mus.26859
PMID:32134516
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8629114/
Abstract

INTRODUCTION

Objective information on longitudinal disease progression in inclusion body myositis (IBM) is lacking.

METHODS

Longitudinal dynamometry and functional status data were collated from a cohort of IBM patients. Annual change was calculated by means of linear modeling. Trajectories of change in grip, knee extension, IBM Functional Rating Scale (IBM-FRS) and Neuromuscular Symptom Score (NSS) were identified by means of latent growth mixture modeling.

RESULTS

Data were collated from 75 IBM patients (348 person-years follow-up). Annual strength loss was greatest for pinch (-10%) and knee extension (-4%). Functional deterioration was greatest for males. Three distinct trajectory groups were identified. Rapid deterioration trajectory for grip strength was associated with younger diagnosis age. Rapid deterioration for knee extension strength was associated with older age of diagnosis.

DISCUSSION

This study has quantified strength change in IBM and identified distinct trajectory groups, which will aid prognostication and stratification for inclusion into future clinical trials.

摘要

简介

包涵体肌炎(IBM)的纵向疾病进展缺乏客观信息。

方法

从 IBM 患者队列中整理了纵向测力和功能状态数据。通过线性建模计算年度变化。通过潜在增长混合建模确定握力、膝关节伸展、IBM 功能评分(IBM-FRS)和神经肌肉症状评分(NSS)变化的轨迹。

结果

共收集了 75 例 IBM 患者(348 人年随访)的数据。捏力(-10%)和膝关节伸展(-4%)的年度力量损失最大。男性功能恶化最严重。确定了三个不同的轨迹组。握力快速恶化轨迹与较年轻的诊断年龄相关。膝关节伸展力量的快速恶化与较晚的诊断年龄相关。

讨论

本研究量化了 IBM 的力量变化,并确定了不同的轨迹组,这将有助于预测和分层,以便纳入未来的临床试验。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/76ac/8629114/224899340000/MUS-62-76-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/76ac/8629114/224899340000/MUS-62-76-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/76ac/8629114/224899340000/MUS-62-76-g001.jpg

相似文献

1
Long-term strength and functional status in inclusion body myositis and identification of trajectory subgroups.包涵体肌炎的长期肌力和功能状态以及轨迹亚组的鉴定。
Muscle Nerve. 2020 Jul;62(1):76-82. doi: 10.1002/mus.26859. Epub 2020 Mar 13.
2
Four-year longitudinal study of clinical and functional endpoints in sporadic inclusion body myositis: implications for therapeutic trials.散发性包涵体肌炎临床和功能终点的四年纵向研究:对治疗试验的影响。
Neuromuscul Disord. 2014 Jul;24(7):604-10. doi: 10.1016/j.nmd.2014.04.009. Epub 2014 May 4.
3
Quadriceps strength is a sensitive marker of disease progression in sporadic inclusion body myositis.股四头肌力量是散发性包涵体肌炎疾病进展的敏感标志物。
Neuromuscul Disord. 2012 Nov;22(11):980-6. doi: 10.1016/j.nmd.2012.05.004. Epub 2012 Jun 26.
4
Optimizing hand-function patient outcome measures for inclusion body myositis.优化包涵体肌炎手部功能患者结局测量指标。
Neuromuscul Disord. 2020 Oct;30(10):807-814. doi: 10.1016/j.nmd.2020.08.358. Epub 2020 Aug 19.
5
Prognosis and prognostic factors in sporadic inclusion body myositis.散发型包涵体肌炎的预后和预后因素。
Acta Neurol Scand. 2012 May;125(5):353-8. doi: 10.1111/j.1600-0404.2011.01584.x. Epub 2011 Sep 14.
6
Longitudinal observational study of sporadic inclusion body myositis: implications for clinical trials.散发性包涵体肌炎的纵向观察性研究:对临床试验的启示。
Neuromuscul Disord. 2013 May;23(5):404-12. doi: 10.1016/j.nmd.2013.02.010. Epub 2013 Mar 11.
7
A cross-sectional study of hand function in inclusion body myositis: Implications for functional rating scale.包涵体肌炎手部功能的横断面研究:对功能评定量表的影响。
Neuromuscul Disord. 2020 Mar;30(3):200-206. doi: 10.1016/j.nmd.2019.12.002. Epub 2019 Dec 17.
8
Modeling functional decline over time in sporadic inclusion body myositis.散发性包涵体肌炎随时间推移的功能衰退建模
Muscle Nerve. 2017 Apr;55(4):526-531. doi: 10.1002/mus.25373. Epub 2016 Dec 28.
9
Clinical Subgroups and Factors Associated With Progression in Patients With Inclusion Body Myositis.包涵体肌炎患者进展相关的临床亚组和因素。
Neurology. 2023 Mar 28;100(13):e1406-e1417. doi: 10.1212/WNL.0000000000206777. Epub 2023 Jan 23.
10
Electrical impedance myography as a biomarker of inclusion body myositis: A cross-sectional study.肌电图作为包涵体肌炎生物标志物的研究:一项横断面研究。
Clin Neurophysiol. 2020 Feb;131(2):368-371. doi: 10.1016/j.clinph.2019.10.030. Epub 2019 Dec 6.

引用本文的文献

1
Characterizing local antibody responses in the muscle of inclusion body myositis patients.表征包涵体肌炎患者肌肉中的局部抗体反应。
J Autoimmun. 2025 Jun;154:103437. doi: 10.1016/j.jaut.2025.103437. Epub 2025 May 26.
2
Strapped for Strength: A Comparison Study of Dynamometry Techniques to Evaluate Knee Extensor Strength in Inclusion Body Myositis.力量不足:评估包涵体肌炎中膝伸肌力量的测力计技术比较研究
Muscle Nerve. 2025 Jul;72(1):42-48. doi: 10.1002/mus.28406. Epub 2025 Apr 3.
3
A systematic review and meta-analysis of the response to placebo in clinical trials of inclusion body myositis.

本文引用的文献

1
Safety and efficacy of intravenous bimagrumab in inclusion body myositis (RESILIENT): a randomised, double-blind, placebo-controlled phase 2b trial.静脉注射双羟苯丙氨酸治疗包涵体肌炎的安全性和有效性(RESILIENT):一项随机、双盲、安慰剂对照的 2b 期临床试验。
Lancet Neurol. 2019 Sep;18(9):834-844. doi: 10.1016/S1474-4422(19)30200-5.
2
Physical function and muscle strength in sporadic inclusion body myositis.散发性包涵体肌炎中的身体功能和肌肉力量
Muscle Nerve. 2017 Dec;56(6):E50-E58. doi: 10.1002/mus.25603. Epub 2017 Apr 10.
3
Cytosolic 5'-nucleotidase 1A autoantibody profile and clinical characteristics in inclusion body myositis.
一项关于包涵体肌炎临床试验中对安慰剂反应的系统评价和荟萃分析。
Rheumatology (Oxford). 2025 Jul 1;64(7):4125-4132. doi: 10.1093/rheumatology/keaf146.
4
Identification of distinct immune signatures in inclusion body myositis by peripheral blood immunophenotyping using machine learning models.使用机器学习模型通过外周血免疫表型分析鉴定包涵体肌炎中不同的免疫特征。
Clin Transl Immunology. 2024 Apr 3;13(4):e1504. doi: 10.1002/cti2.1504. eCollection 2024.
5
Clinical Subgroups and Factors Associated With Progression in Patients With Inclusion Body Myositis.包涵体肌炎患者进展相关的临床亚组和因素。
Neurology. 2023 Mar 28;100(13):e1406-e1417. doi: 10.1212/WNL.0000000000206777. Epub 2023 Jan 23.
6
Correlations of disease severity outcome measures in inclusion body myositis.包涵体肌炎疾病严重程度结局测量指标的相关性。
Neuromuscul Disord. 2022 Oct;32(10):800-805. doi: 10.1016/j.nmd.2022.08.005. Epub 2022 Aug 24.
7
Optimizing hand-function patient outcome measures for inclusion body myositis.优化包涵体肌炎手部功能患者结局测量指标。
Neuromuscul Disord. 2020 Oct;30(10):807-814. doi: 10.1016/j.nmd.2020.08.358. Epub 2020 Aug 19.
包涵体肌炎中胞质5'-核苷酸酶1A自身抗体谱及临床特征
Ann Rheum Dis. 2017 May;76(5):862-868. doi: 10.1136/annrheumdis-2016-210282. Epub 2017 Jan 25.
4
Modeling functional decline over time in sporadic inclusion body myositis.散发性包涵体肌炎随时间推移的功能衰退建模
Muscle Nerve. 2017 Apr;55(4):526-531. doi: 10.1002/mus.25373. Epub 2016 Dec 28.
5
Seropositivity for NT5c1A antibody in sporadic inclusion body myositis predicts more severe motor, bulbar and respiratory involvement.散发性包涵体肌炎中NT5c1A抗体血清阳性预示着更严重的运动、延髓和呼吸受累。
J Neurol Neurosurg Psychiatry. 2016 Apr;87(4):373-8. doi: 10.1136/jnnp-2014-310008. Epub 2015 Apr 9.
6
Disease specificity of autoantibodies to cytosolic 5'-nucleotidase 1A in sporadic inclusion body myositis versus known autoimmune diseases.散发性包涵体肌炎中抗胞质5'-核苷酸酶1A自身抗体相对于已知自身免疫性疾病的疾病特异性
Ann Rheum Dis. 2016 Apr;75(4):696-701. doi: 10.1136/annrheumdis-2014-206691. Epub 2015 Feb 24.
7
Four-year longitudinal study of clinical and functional endpoints in sporadic inclusion body myositis: implications for therapeutic trials.散发性包涵体肌炎临床和功能终点的四年纵向研究:对治疗试验的影响。
Neuromuscul Disord. 2014 Jul;24(7):604-10. doi: 10.1016/j.nmd.2014.04.009. Epub 2014 May 4.
8
The 2-min walk test is sufficient for evaluating walking abilities in sporadic inclusion body myositis.2 分钟步行试验足以评估散发型包涵体肌炎的步行能力。
Neuromuscul Disord. 2014 Mar;24(3):222-6. doi: 10.1016/j.nmd.2013.11.012. Epub 2013 Dec 1.
9
Autoantibodies to cytosolic 5'-nucleotidase 1A in inclusion body myositis.包涵体肌炎中胞质 5'-核苷酸酶 1A 的自身抗体。
Ann Neurol. 2013 Mar;73(3):397-407. doi: 10.1002/ana.23822. Epub 2013 Mar 4.
10
Quadriceps strength is a sensitive marker of disease progression in sporadic inclusion body myositis.股四头肌力量是散发性包涵体肌炎疾病进展的敏感标志物。
Neuromuscul Disord. 2012 Nov;22(11):980-6. doi: 10.1016/j.nmd.2012.05.004. Epub 2012 Jun 26.